NCT05775471 2026-02-05Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial CancerJonsson Comprehensive Cancer CenterPhase 2 Recruiting21 enrolled